| Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU/1/09/578/001 |
Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1) |
GlaxoSmithKline Biologicals S.A. |
— |
| Alli EU/1/07/401/12-15 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/1-6 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/7-11 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Ambirix suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/005 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/001 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/002 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/003 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/004 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) |
GlaxoSmithKline Biologicals S.A. |
— |
| ANORO ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/898/001-003 |
Vilanterol trifenatate, Umeclidinium bromide |
GlaxoSmithKline Trading Services Limited |
— |
| Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) EU/1/23/1740/001-002 |
Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E |
GlaxoSmithKline Biologicals |
— |
| Augmentin 250 mg/125 mg film-coated tablets PA1077/093/007 |
Amoxicillin, Clavulanic acid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Augmentin 500 mg/125 mg film-coated tablets PA1077/019/003 |
Amoxicillin, Clavulanic acid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Augmentin 875 mg/125 mg film-coated tablets PA1077/019/005 |
Amoxicillin, Clavulanic acid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension PA1077/019/006 |
Amoxicillin, Clavulanic acid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension PA1077/093/004 |
Amoxicillin, Clavulanic acid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| AVAMYS 27.5 micrograms/spray, nasal spray suspension EU/1/07/434/001-003 |
Fluticasone furoate |
GlaxoSmithKline Trading Services Limited |
— |
| Avodart 0.5 mg soft capsules PA1077/104/001 |
Dutasteride |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Bactroban 2% w/w Nasal Ointment PA1077/094/002 |
Mupirocin calcium |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Bactroban 2% w/w Ointment PA1077/094/001 |
Mupirocin |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Becotide Evohaler 100 micrograms, Pressurised Inhalation Solution PA1077/042/007 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution PA1077/042/009 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution PA1077/042/006 |
Beclometasone dipropionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Benlysta 120 mg powder for concentrate for solution for infusion EU/1/11/700/001-002 |
Belimumab |
GlaxoSmithKline (Ireland) Limited |
— |
| Benlysta 200 mg solution for injection in pre-filled pen EU/1/11/700/003-005 |
Belimumab |
GlaxoSmithKline (Ireland) Limited |
— |
| Benlysta 200 mg solution for injection in pre-filled syringe EU/1/11/700/006-007 |
Belimumab |
GlaxoSmithKline (Ireland) Limited |
— |
| Betnovate Cream 0.1% w/w PA1077/001/001 |
Betamethasone |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Betnovate Ointment 0.1% w/w PA1077/001/002 |
Betamethasone valerate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Betnovate Scalp Application 0.1% w/w Cutaneous Solution PA1077/001/003 |
Betamethasone |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Bexsero 0.5 ml suspension for injection in pre-filled syringe EU/1/12/812/001-004 |
Recombinant neisseria meningitidis serogroup b nhba fusion protein, Recombinant neisseria meningitidis serogroup b nada fusion protein, Recombinant neisseria meningitidis serogroup b fhbp fusion protein, Outer rmembrane vesicles (omv) |
Glaxosmithkline Vaccines S.r.l. |
— |
| BLENREP 100 mg powder for concentrate for solution for infusion EU/1/25/1948/002 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| BLENREP 70 mg powder for concentrate for solution for infusion EU/1/25/1948/001 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content) PA1077/020/001 |
Pertactin, Filamentous haemagglutinin, Pertussis toxoid, Tetanus toxoid, Diphtheria toxoid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Cervarix suspension for injection Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) EU/1/07/419/1-12 |
Hpv 16 l1 protein, Hpv 18 l1 protein |
GlaxoSmithKline Biologicals S.A. |
— |
| Combodart 0.5 mg/ 0.4 mg hard capsules PA1077/118/001 |
Dutasteride, Tamsulosin hydrochloride |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Dectova 10 mg/mL solution for infusion EU/1/18/1349/001 |
Zanamivir |
GlaxoSmithKline Trading Services Limited |
— |
| Dermovate 0.05% w/w Cream PA1077/005/001 |
Clobetasol propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Dermovate 0.05% w/w Ointment PA1077/005/002 |
Clobetasol propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Dermovate Scalp Application 0.05% w/v Cutaneous Solution PA1077/005/003 |
Clobetasol propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Duac Once Daily 10mg/g + 50mg/g Gel PA1077/120/001 |
CLINDAMYCIN PHOSPHATE, Benzoyl peroxide hydrous |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/17/1237/001-003 |
Fluticasone furoate, Umeclidinium bromide, Vilanterol trifenatate |
GlaxoSmithKline Trading Services Limited |
— |
| Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV) PA1077/023/002 |
Hepatitis b surface antigen, recominant |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Eumovate Cream 0.05% w/w PA1077/006/001 |
CLOBETASONE BUTYRATE |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Fendrix suspension for injection EU/1/04/0299/001-003 |
Hepatitis b vaccine |
GlaxoSmithKline Biologicals S.A. |
— |
| Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensed PA1077/044/010 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensed PA1077/044/011 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensed PA1077/044/009 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensed PA1077/044/012 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation Suspension PA1077/044/014 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation, Suspension PA1077/044/015 |
Fluticasone propionate |
GlaxoSmithKline (Ireland) Limited |
Marketed |